Beiersdorf Aktiengesellschaft
5-year stock timeline
Beiersdorf (BEI.XETRA) has spent the past five years as a resilient, steadily compounding European consumer staples name, punctuated by underperformance in 2021 and 2024–2025 that bracketed strong re-rating years in 2022–2023. At 106.5 EUR, the stock reflects what you'd expect from a high-quality defensive compounder that's recently been marked down.
2022: Strategy 2025 gains traction
Beiersdorf delivered double-digit reported sales growth, helped by price/mix gains and recovery in core brands like Nivea. EBIT and net income expanded strongly year on year, signalling that investment behind C.A.R.E.+ and Strategy 2025 was translating into profitable growth. The stock gained around 21% as investors began to see the name as a steady compounder with visible margin and earnings upgrades, rather than a low-growth value trap.
2023: A defensive compounder in a volatile market
Net sales continued to rise and EBIT expanded, supported by ongoing premiumization and strong performance in skin care and derma. The share price surged roughly 30%, helped by repeated guidance confirmations and modest upgrades, as investors rotated into high-quality European staples. The narrative shifted decisively: fortress brand, slow but reliable compounder.
2024: From peak optimism to de-rating
In May, the stock reached an all-time closing high near 158 EUR, capping a multi-year uptrend. From there it entered a significant corrective phase. Through the year, the share delivered double-digit negative returns (about −11%), as investors worried about slower sector growth, normalization after strong post-pandemic pricing, and a rich valuation. The story became "great business, fully priced," and the chart shifted from strong uptrend to a broad, volatile range with a clear downward bias.
2025–early 2026: Range-bound trading
Beiersdorf's 9M 2025 update showed results in line with expectations in a challenging market—solid but unspectacular growth, with the business remaining resilient as category growth cooled. Down about 7% in 2025 and now at 106.5 EUR, investor perception has evolved toward a high-quality, cash-generative consumer staples name that may be modestly undervalued versus fundamentals. Over the last 12–18 months, the chart shows a completed major uptrend, followed by a drawn-out de-rating phase, and now more range-bound trading as valuation and expectations re-equilibrate.
Key risks and downside factors
BEI.XETRA is Beiersdorf AG, a German multinational with a portfolio spanning skin care and adhesives. The skin care side runs Nivea, Eucerin, and La Prairie across mass-market and premium segments. Tesa handles specialty adhesives. They're competing against entrenched global players with deep pockets for marketing and shifting consumer tastes—everyone's chasing dermatological credibility and sustainability claims these days. The headwinds are familiar: brand pressure, raw material costs that won't stay still, regulatory tightening in cosmetics and chemicals, and consumers pulling back when wallets get tight.
- Global beauty and personal care competitors pose a real threat to Beiersdorf's pricing flexibility, brand positioning, and footing in core skin care markets.
- Rising costs for raw materials, packaging, and energy—combined with supply chain disruptions—could squeeze margins if Beiersdorf struggles to pass these expenses along to consumers.
- Tightening regulations across the EU and other markets—covering cosmetics, chemicals, sustainability, and product safety—could push up compliance costs, limit formulation options, or force product withdrawals.
- Economic slowdowns or consumer pullback toward value products—particularly in Europe and emerging markets—could dampen demand for premium skin care and weigh on Beiersdorf's growth trajectory.
Competitive landscape
Beiersdorf Aktiengesellschaft (BEI.XETRA) is a German consumer goods company built around skin and body care—NIVEA, Eucerin, La Prairie among them—with a separate industrial adhesives business under the tesa brand. It competes across geographies against both large multinational personal care manufacturers and nimble regional specialists, from Europe to the Americas to Asia. The company operates in a landscape shaped by brand-driven competition, exposure to input cost and currency swings, and the constant pressure to innovate in order to hold its premium positioning. Its geographic spread and portfolio strength offer some buffer against volatility, though they also mean exposure to the regulatory and macroeconomic shifts happening simultaneously across multiple markets.
| Company | Ticker |
|---|---|
| L'Oréal S.A. | OR.EPA |
| The Estée Lauder Companies Inc. | EL.NYSE |
| Unilever PLC | ULVR.LSE |
| Procter & Gamble Co. | PG.NYSE |
| Colgate-Palmolive Company | CL.NYSE |
| Henkel AG & Co. KGaA | HEN3.XETRA |
| Johnson & Johnson | JNJ.NYSE |
Private competitors
- Beiersdorf subsidiary La Prairie Group AG
- Beiersdorf subsidiary tesa SE
- Coty-owned Bourjois and regional skincare brands (competitive set in mass and premium beauty)
- Regional dermocosmetic and pharmacy brands in Europe and emerging markets
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialPerformance Figures of Beiersdorf Aktiengesellschaft
Relative Performance vs Benchmarks
| Period | Beiersdorf Aktiengesellschaft | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | +9.59% | +8.60% | +9.56% |
| 3M | +15.58% | +8.41% | +13.14% |
| 6M | +7.66% | +3.08% | +0.43% |
| 1Y | -16.19% | -29.02% | -32.46% |
| 3Y | -3.74% | -69.08% | -84.68% |
| 5Y | +30.17% | -49.76% | -58.35% |
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHistorical valuation trends
How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 39.2 | 3.3 | 2.8 | 29.7 |
| 1Y ago | 17.2 | 1.5 | 3.4 | 12.7 |
| 3Y ago | 22.5 | 1.9 | 3.3 | 35.1 |
| 5Y ago | 22.7 | 1.8 | 3.1 | 12.9 |
Key Metrics
Valuation Metrics
Profitability Metrics
Growth Metrics
Dividend history
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
| Year | Dividend | Yield at payment | Avg. yield |
|---|---|---|---|
| 2025 | 1.00 EUR | 0.84% | 0.89% |
| 2024 | 1.00 EUR | 0.74% | |
| 2023 | 0.70 EUR | 0.57% | |
| 2022 | 0.70 EUR | 0.74% | |
| 2021 | 0.70 EUR | 0.78% | |
| 2020 | 0.70 EUR | 0.74% | |
| 2019 | 0.70 EUR | 0.76% | |
| 2018 | 0.70 EUR | 0.76% | |
| 2017 | 0.70 EUR | 0.77% | |
| 2016 | 0.70 EUR | 0.88% | |
| 2015 | 0.70 EUR | 0.87% | |
| 2014 | 0.70 EUR | 0.99% | |
| 2013 | 0.70 EUR | 1.03% | |
| 2012 | 0.70 EUR | 1.33% | |
| 2011 | 0.70 EUR | 1.57% |
Earnings history & estimates
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Historical earnings performance
Upcoming earnings report
Analyst estimates for upcoming periods
Key financial figures
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Revenue | 9.85B | 9.45B | 8.80B | 7.63B | 7.03B |
| Operating income (EBIT) | 1.30B | 1.10B | 1.22B | 980.00M | 918.00M |
| Net income | 912.00M | 736.00M | 755.00M | 638.00M | 560.00M |
| Free cash flow | 794.00M | 424.00M | 249.00M | 580.00M | 704.00M |
| Total assets | 13.01B | 12.63B | 12.35B | 11.30B | 10.21B |
| Equity | 8.47B | 8.32B | 7.79B | 6.87B | 6.24B |
| Net debt | -941.00M | -1.03B | -722.00M | -757.00M | -790.00M |
PWP Leeway UG (haftungsbeschränkt)
